Hillary Clinton praised for diplomatic leverage and NGO outreachEmail from Richard Kahn questioning Trump’s path to victory without Pennsylvania
1 duplicate copy in the archive
Title Match
Case Filed-35488House OversightFund Disclosure on Pharmaceutical Policy Risks and Investment Capital Constraints
November 11, 20251p2 persons
Case File
d-35488House OversightFund Disclosure on Pharmaceutical Policy Risks and Investment Capital Constraints
Other
The passage outlines generic investment risk disclosures and proposed pharmaceutical reforms without naming specific high‑profile individuals, transactions, or novel allegations. It offers limited act Describes potential reforms affecting drug pricing, rebates, and marketing regulations. Notes risk that proposed reforms could reduce fund returns on biopharma investments. Highlights capital constra
Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #024072
Pages
1
Persons
2
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.